Financials
Financial year 2025
XperMed from Liège, company number BE0686626475, closed financial year 2025 with a result of € -20,133 after tax. For that financial year XperMed recorded a gross margin of € 26,808 and equity of € 64,193. Compared with financial year 2024, the result moved from € 36,161 to € -20,133. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 64,193
▼ 24% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -20,133
▼ still € 36,161 profit in 2024
Profit after tax over the fiscal year.
€ 84,474
▲ 40% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 45,593.
People and assets in 2025
€ 2,888
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 181,189
▼ 15% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 202,110
▼ 11% vs 2024
€ 29,728 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 13,794
▲ 214% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 10,750
▲ 7% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 120 | € 36,941 | € 79,264 | € 26,808 | ▼ 66% |
| Profit after taxes | € -15,436 | € 15,325 | € 36,161 | € -20,133 | ▼ € 56,294 |
| Equity | € 32,841 | € 48,166 | € 84,327 | € 64,193 | ▼ 24% |
| Total debts | € 120,614 | € 122,373 | € 299,882 | € 288,607 | ▼ 4% |
| Cash | € 67,068 | € 88,847 | € 60,302 | € 84,474 | ▲ 40% |
| Land & buildings | € 1,877 | € 14,894 | € 35,956 | € 31,607 | ▼ 12% |
| Retained profit | € 14,241 | € 29,566 | € 65,727 | € 45,593 | ▼ 31% |
| Dividend | € 28,000 | € 0 | € 0 | € 0 | |
| Bank debt | € 63,789 | € 50,000 | € 226,426 | € 202,110 | ▼ 11% |
| Balance sheet total | € 161,056 | € 176,598 | € 388,685 | € 355,742 | ▼ 8% |
Key figures of XperMed, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to XperMed?
What happened at XperMed in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 20,133 (▼ € 56,294 vs 2024). filed late Source: NBB ↗
- ALAIN NCHIMI LONGANG became a director. NBB
- LUABA TSHIBANDA became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 15,436 loss in 2022 to € 20,133 loss in 2025.
Paid € 14,099 in corporate taxes since 2022.
Best year ever: 2024, with € 36,161 profit.
Paid out € 28,000 in dividends to the owners in total.
A new publication or filing at XperMed? We notify you, reason included.
Follow XperMedDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind XperMed are ALAIN NCHIMI LONGANG and LUABA TSHIBANDA.
Directors
According to the 2025 annual accounts
ALAIN NCHIMI LONGANG
Director
since 2022
LUABA TSHIBANDA
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Vaudrée 40
4031 Liège
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0686.626.475
- VAT number
- BE 0686.626.475
- Registered office
- Rue Vaudrée 40, 4031 Liège
- Names & denominations
- XperMed
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 December 2017
- Peppol
- Active · Active since 17 Dec 2025
- Activities · NACE
Activiteiten van medisch specialisten